Fein S A, Frishman W H
Albany Medical College, New York.
Cardiol Clin. 1987 Nov;5(4):563-76.
Primary pulmonary hypertension is a relatively rare disease with a poorly understood pathophysiology, limited therapeutic options, and a dismal prognosis. The advantages and disadvantages of different pharmacologic approaches for this condition are discussed in this article.
原发性肺动脉高压是一种相对罕见的疾病，其病理生理学机制尚不清楚，治疗选择有限，预后不佳。本文讨论了针对这种疾病的不同药物治疗方法的优缺点。
